Artal Group S.A.
- SEC CIK
- 0001053906
- Latest filing
- Aug 13, 2026
RXRX holding history
Recursion Pharmaceuticals, Inc. in every 13F filed by Artal Group S.A., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RXRX overviewAll 13F holders of RXRXFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −960,204−100.0% | Sold out | Holders |
| Q4 2022 | 960,204 | $7.40M | 0.4% | +510,204+113.4% | Added | Holders |
| Q3 2022 | 450,000 | $4.79M | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2022 | 450,000 | $3.66M | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2022 | 450,000 | $3.22M | 0.1% | +250,000+125.0% | Added | Holders |
| Q4 2021 | 200,000 | $3.43M | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 200,000 | $4.60M | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 200,000 | $7.30M | 0.2% | +200,000 | New | Holders |